Starting this Thread to demonstrate the upcoming year of Trials ahead for Pharmaust.
The title says it all.
Human Covid Trial , Multiple Clinics in discussion with PAA adding to the pool of positive data gained from WEHI from 2 Independent Trials, Biolabs 360 and the Leiden University in Holland.
MPL in the Lab demonstrated that MPL can reduce the Viral Load by 50% in the first 24 hours and 95% over the coming 72 hours,,
This Trial should be short and swift and from the reputation of the above institutes the results will be replicable.
Leading to a safe robust Treatment that should reduce Hospitalisation times and assist those that have contracted Covid and possibly the entire SARs-1 and SARs-2 family, this would be a breakthrough Treatment.
MND Motor Neuron Disease , Fully Funded by MND Australia
K9 Phase III , specialist negotiator brought on board to secure a Phase III K9 Lymphoma Trial Partner or early Commercial Deal.
The Company already has solid confirmation of the benefits of MPL and now wish to trial with a companion drug to increase the benefits to K9's , this data will be utilised for the upcoming Human Trials.
Human Oncology , PAA intend to replicate the Positive Results from the 2016 Human Cancer Trial negating any of the previous minor adverse effects. This will be a "Take at Home" cancer treatment with no harmful adverse side effects negating the use of aggressive Chemotherapy.
HVTL-1 Based Virus the cousin of HIV and a precursor to Leukemia ,WEHI identified Positive effect of MPL.
The company are awaiting the delivery of refined and micronised MPL , "Pharmapantel" the Tablets/Pill has been designed to be very small to reduce patient burden and easier to swallow.
2022 is Pharmausts year in the Spotlight , NZT
- Forums
- ASX - By Stock
- PAA
- PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
- There are more pages in this discussion • 1,466 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
17.5¢ |
Change
0.005(2.94%) |
Mkt cap ! $69.28M |
Open | High | Low | Value | Volume |
17.5¢ | 18.5¢ | 17.5¢ | $427.5K | 2.394M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 103443 | 17.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 130237 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 103443 | 0.175 |
14 | 877793 | 0.170 |
8 | 314499 | 0.165 |
10 | 268362 | 0.160 |
3 | 169555 | 0.155 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 102237 | 2 |
0.185 | 37597 | 1 |
0.190 | 25000 | 1 |
0.195 | 208000 | 4 |
0.200 | 130000 | 4 |
Last trade - 16.10pm 13/05/2024 (20 minute delay) ? |
|
|||||
Last
18.0¢ |
  |
Change
0.005 ( 3.51 %) |
|||
Open | High | Low | Volume | ||
17.5¢ | 18.5¢ | 17.5¢ | 1774886 | ||
Last updated 15.59pm 13/05/2024 ? |
Featured News
PAA (ASX) Chart |
The Watchlist
MGU
MAGNUM MINING AND EXPLORATION LIMITED
Neil Goodman, MD
Neil Goodman
MD
SPONSORED BY The Market Online